AI-Powered Diagnostic Quantitative Insights offers QuantX, an FDA-cleared AI-based computer-aided diagnosis system that improves radiologist performance and reduces missed cancers, presenting a compelling value proposition for hospitals and imaging centers seeking to enhance diagnostic accuracy and patient outcomes.

Breast Cancer Focus The QuantX platform supports a broad range of breast cancer decision support tools, including the QI Score and Similar Case Database Compare, creating multiple upsell opportunities for radiology departments and pathology workflows within breast imaging programs.

Low-Volume Advantage With a small team and revenue under one million, there is an opportunity to partner with mid to large clinics seeking scalable AI solutions, offering flexible deployment, training, and support to accelerate adoption and generate repeatable revenue streams.

University Origins As a UC spinoff with recognized leadership (e.g., iCON Innovator Award), leverage credibility to engage academic medical centers and teaching hospitals that prioritize innovative imaging solutions and research collaborations.

Competitive Positioning Position QuantX against other AI imaging players by emphasizing cost reduction, faster reading times, and improved cancer detection, while targeting facilities already evaluating AI/CAD tools and seeking evidence-based performance improvements.